Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
JCI Insight|February 1, 2017
GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistanceRuby Kuang, Arman Jahangiri, Smita Mascharak, et al.
Neuro-Oncology|October 10, 2015
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II studyNicholas Butowski, Howard Colman, John F De Groot, et al.
Neuro-Oncology|March 25, 2017
A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) studyAnuradha Banerjee, Regina I Jakacki, Arzu Onar-Thomas, et al.
Neuro-Oncology|May 30, 2019
Polysomy is associated with poor outcome in 1p/19q codeleted oligodendroglial tumorsHui Chen, Cheddhi Thomas, Felipe Andres Munoz, et al.
Neurosurgery|August 30, 2020
A Prognostic Gene-Expression Signature and Risk Score for Meningioma Recurrence After ResectionWilliam C Chen, Harish N Vasudevan, Abrar Choudhury, et al.
JAMA Network Open|August 17, 2023
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to ImmunotherapyHarish N Vasudevan, Cyrille Delley, William C Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2025
Measles Oncolytic Virus as an Immunotherapy for Recurrent/Refractory Pediatric Medulloblastoma and Atypical Teratoid/Rhabdoid Tumor: Results from PNOC005Bohyeon Yu, Cassie Kline, Owen Hoare, et al.
Research Square|June 12, 2026
A proteogenomic RNA processing mechanism drives sex differences in meningiomaDavid Raleigh, Martha Cady, Ayush Aggarwal, et al.
Acta Neuropathologica|May 21, 2014
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entityTara Spence, Patrick Sin-Chan, Daniel Picard, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Pageof 4